Thomas Barnetche Selected Research

Antirheumatic Agents (DMARD)

1/2023	Risk of Cancer After Initiation of Targeted Therapies in Patients With Rheumatoid Arthritis and a Prior Cancer: Systematic Review With Meta-Analysis.
12/2021	Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases.
1/2021	Use of eHealth by Patients With Rheumatoid Arthritis: Observational, Cross-sectional, Multicenter Study.
1/2021	Most Appropriate Conventional Disease-Modifying Antirheumatic Drug to Combine With Different Advanced Therapies in Rheumatoid Arthritis: A Systematic Literature Review With Meta-Analysis.
5/2020	Biological DMARD efficacy in psoriatic arthritis: a systematic literature review and meta-analysis on articular, enthesitis, dactylitis, skin and functional outcomes.
1/2020	Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review.
1/2018	Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis.
3/2016	Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry.
9/2012	Risk of malignancy including non-melanoma skin cancers with anti-tumor necrosis factor therapy in patients with rheumatoid arthritis: meta-analysis of registries and systematic review of long-term extension studies.
4/2012	Short-term risk of total malignancy and nonmelanoma skin cancers with certolizumab and golimumab in patients with rheumatoid arthritis: metaanalysis of randomized controlled trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Barnetche Research Topics

Disease

22	Rheumatoid Arthritis 01/2023 - 02/2006
9	Neoplasms (Cancer) 11/2023 - 04/2012
6	Necrosis 03/2023 - 09/2012
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2016
5	Psoriatic Arthritis 01/2023 - 02/2014
4	Rheumatic Diseases (Rheumatism) 06/2021 - 03/2017
3	Arthritis (Polyarthritis) 11/2023 - 12/2017
3	Infections 01/2022 - 07/2017
2	Systemic Scleroderma (Systemic Sclerosis) 11/2023 - 01/2018
2	COVID-19 10/2022 - 01/2022
2	Disease Progression 10/2022 - 11/2020
2	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2022 - 12/2021
2	Melanoma (Melanoma, Malignant) 12/2021 - 09/2012
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 01/2018
2	Human Influenza (Influenza) 01/2016 - 07/2014
2	Inflammation (Inflammations) 12/2015 - 06/2012
2	Skin Neoplasms (Skin Cancer) 09/2012 - 04/2012
1	Folliculitis (Sycosis) 03/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023
1	Axial Spondyloarthritis 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Synovitis 01/2023
1	Spondylarthropathies 03/2022
1	Vitiligo 12/2021
1	digital ulcers 06/2021
1	Pain (Aches) 06/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Neoplasm Metastasis (Metastasis) 11/2020
1	Colorectal Neoplasms (Colorectal Cancer) 11/2020
1	Avitaminosis (Vitamin Deficiency) 01/2019
1	Morbid Obesity 01/2019
1	Heart Failure 01/2019
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 12/2018
1	Neonatal Systemic lupus erythematosus 12/2018
1	Ankylosing Spondylitis 10/2018
1	Pericardial Effusion 02/2018
1	Atrial Fibrillation 02/2018
1	Ventricular Fibrillation 02/2018
1	Heart Block 02/2018
1	Pruritus (Itching) 01/2018

Drug/Important Bio-Agent (IBA)

10	Antirheumatic Agents (DMARD)IBA 01/2023 - 04/2012
6	Tumor Necrosis Factor InhibitorsIBA 01/2023 - 06/2012
5	AntibodiesIBA 01/2023 - 09/2015
4	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2021 - 01/2018
4	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 07/2013
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2017
3	Rituximab (Mabthera)FDA Link 01/2023 - 07/2014
3	tocilizumab (atlizumab)FDA Link 03/2021 - 06/2012
3	Anti-Citrullinated Protein AntibodiesIBA 01/2018 - 03/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2017 - 09/2012
2	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2018
2	Infliximab (Remicade)FDA Link 03/2023 - 10/2018
2	Adalimumab (Humira)FDA Link 03/2023 - 01/2018
2	Monoclonal AntibodiesIBA 10/2022 - 05/2011
2	InterferonsIBA 01/2021 - 01/2016
2	AutoantibodiesIBA 01/2021 - 01/2018
2	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2016 - 07/2014
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2008 - 02/2006
1	Silicon Dioxide (Silica)FDA LinkGeneric 11/2023
1	SolventsIBA 11/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Anti-Idiotypic AntibodiesIBA 01/2023
1	Semaphorins (Semaphorin)IBA 01/2023
1	amsonic acid (DAS)IBA 01/2023
1	RNA Polymerase IIIIBA 01/2023
1	GadoliniumIBA 03/2022
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2022
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2022
1	Galectins (Galectin)IBA 01/2022
1	Botulinum Toxins (Botulinum Toxin)IBA 06/2021
1	SelectinsIBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 11/2020
1	InflammasomesIBA 11/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2019
1	Interleukin-12 (IL 12)IBA 01/2019
1	InterleukinsIBA 01/2019
1	omega-Chloroacetophenone (Mace)IBA 01/2019
1	Biosimilar PharmaceuticalsIBA 10/2018
1	CT-P13IBA 10/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Rheumatoid FactorIBA 01/2018
1	Janus Kinase InhibitorsIBA 01/2018
1	apremilastIBA 01/2018
1	cyclic citrullinated peptideIBA 01/2018
1	ImmunosorbentsIBA 12/2017
1	Proteins (Proteins, Gene)FDA Link 12/2017
1	EnzymesIBA 12/2017
1	B-Cell Activating FactorIBA 10/2017
1	DNA (Deoxyribonucleic Acid)IBA 10/2017
1	Abatacept (Orencia)FDA Link 03/2016
1	Toll-Like Receptor 7IBA 01/2016

Therapy/Procedure

11	Therapeutics 03/2023 - 05/2011
2	Biological Therapy 05/2020 - 01/2019
1	Length of Stay 01/2022
1	Injections 06/2021
1	Bariatric Surgery 01/2019
1	Stents 02/2018
1	Phototherapy (Light Therapy) 01/2018
1	Operative Surgical Procedures 07/2017